FRESENIUS SE MTN 20/27FRESENIUS SE MTN 20/27FRESENIUS SE MTN 20/27

FRESENIUS SE MTN 20/27

No trades
See on Supercharts

FREC analysis



Key facts


Issue date
Apr 8, 2020
Maturity date
Oct 8, 2027
Outstanding amount
‪750.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
1,000.00EUR
Coupon
1.63% (Fixed)
Yield to maturity
2.64%
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.